Probing the many benefits of GLP-1 receptor agonists
RESEARCH HIGHLIGHT 05 October 2026 Glucagon-like peptide 1 (GLP-1) receptor agonists are approved for the treatment of type…
Student explores new treatments for depression, addiction
A pharmacist and PhD candidate in medicinal chemistry at the University of Toledo, United States, Trust Nwaka, is…
UPDATE: FDA expands recall of blood pressure medication to include 13K+ bottles | Local News
UPDATE: The recall of a blood pressure medication has been expanded to a Class II recall involving more…
Anxiety drug Xanax under nationwide recall, FDA says | Local News
The U.S. Food and Drug Administration (FDA) announced the recall of anti-anxiety medication Xanax. The recall is for…
Check for black particles: Children’s ibuprofen recalled | Local News
Strides Pharma Inc. has initiated a voluntary nationwide recall of more than 89,000 bottles of children’s liquid ibuprofen…
Older chemical libraries yield new leads for next-generation COVID-19 antivirals
SARS‑CoV‑2, the virus that causes COVID-19, continues to mutate, with some newer strains becoming less responsive to current…
Residents can safely drop off unused medications during prescription drug take back program this month | Local News
Join Together Northern Nevada (JTNN), in collaboration with local law enforcement, the Drug Enforcement Administration, and community partners,…
Synthetic lethality in cancer drug discovery: challenges and opportunities
Hartwell, L. H., Szankasi, P., Roberts, C. J., Murray, A. W. & Friend, S. H. Integrating genetic approaches…